No change on serum neurofilament light chain concentrations in patients with multiple sclerosis switching from 4 to 6 weeks interval between natalizumab infusions

被引：0
|
作者：
Johnsson, M. [1 ]
Farman, H. [1 ]
Lycke, J. [1 ]
Novakova, L. [1 ]
Malmestrom, C. [1 ]
Zetterberg, H. [2 ,3 ,4 ,5 ]
Blennow, K. [2 ,3 ]
Axelsson, M. [1 ]
机构：
[1] Sahlgrens Acad, Inst Neurosci & Physiol, Dept Clin Neurosci, Gothenburg, Sweden
[2] Sahlgrens Acad, Dept Psychiat & Neurochem, Inst Neurosci & Physiol, Gothenburg, Sweden
[3] Sahlgrens Univ Hosp, Clin Neurochem Lab, Molndal, Sweden
[4] UCL Inst Neurol, Dept Neurodegenerat Dis, London, England
[5] UCL, UK Dementia Res Inst, London, England
来源：
MULTIPLE SCLEROSIS JOURNAL | 2021年 / 27卷 / 2_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P936
引用
收藏
页码：764 / 764
页数：1
相关论文
共 50 条
  • [21] Serum neurofilament light levels in natalizumab-treated patients with multiple sclerosis who switch to extended interval dosing from every-4-week dosing in real-world clinical practice
    Foley, John
    Xiong, Kuangnan
    Hoyt, Tammy
    Singh, Carol M.
    Riddle, Evan
    de Moor, Carl
    Plavina, Tatiana
    Campbell, Nolan
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 (02) : 196 - 205
  • [22] Reader Response: Serum Neurofilament Light Association With Progression in Natalizumab-Treated Patients With Relapsing-Remitting Multiple Sclerosis
    Kropshofer, Harald
    Haering, Dieter A.
    Kappos, Ludwig
    Leppert, David
    Kuhle, Jens
    NEUROLOGY, 2022, 98 (11) : 470 - 471
  • [23] Serum neurofilament light chain identifies multiple sclerosis patients with severe focal axonal damage in a 6-year longitudinal cohort
    Steffen, F.
    Uphaus, T.
    Fleischer, V.
    Schraad, M.
    Groppa, S.
    Zipp, F.
    Bittner, S.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 588 - 588
  • [24] Serum neurofilament light chain levels correlate strongly with cognitive status in patients with relapsing and progressive multiple sclerosis
    Edwards, K.
    Kamath, A.
    O'Connor, J.
    Kamath, V.
    Whidden, C.
    Button, A.
    Button, J.
    Bruso, P.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 (08) : NP6 - NP8
  • [25] Serum Neurofilament Light Chain Levels as a Biomarker of Disease Activity, Progression and Treatment Response in Patients with Multiple Sclerosis
    Fabis-Pedrini, Marzena
    Kaskow, Belinda
    Trend, Stephanie
    Carroll, William
    Walters, Sue
    Maceski, Aleksandra
    Kuhle, Jens
    Kermode, Allan
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 (07) : NP2 - NP2
  • [26] Serum neurofilament light chain as a predictive marker in patients after first demyelinating event suggestive of multiple sclerosis
    Benova, B.
    Barro, C.
    Andelova, M.
    Uher, T.
    Michalak, Z.
    Tyblova, M.
    Kucerova, K.
    Hrnciarova, T.
    Vaneckova, M.
    Kadrnozkova, L.
    Motyl, J.
    Havrdova, E.
    Kuhle, J.
    Horakova, D.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 450 - 450
  • [27] Gd plus Lesions Impacts On The Association Between Age And Serum Neurofilament Light In Patients With Multiple Sclerosis
    Rosso, M.
    Healy, B. C.
    Saxena, S.
    Paul, A.
    Kuhle, J.
    Leppert, D.
    Guttmann, C.
    Bakshi, R.
    Weiner, H. L.
    Chitnis, T.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (1_SUPPL) : 20 - 21
  • [28] Serum neurofilament light chain levels identify multiple sclerosis patients with severe focal axonal damage in a 6-year longitudinal cohort
    Bittner, S.
    Uphaus, T.
    Steffen, F.
    Fleischer, V.
    Groppa, S.
    Zipp, F.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (1_SUPPL) : 46 - 46
  • [29] The association between serum neurofilament light chain, atrophied lesion volume and brain atrophy with disability progression in multiple sclerosis
    Tavazzi, Eleonora
    Ramanathan, Murali
    Barro, Christian
    Hagemeier, Jesper
    Jakimovski, Dejan
    Bergsland, Niels
    Tomic, Davorka
    Kropshofer, Harald
    Leppert, David
    Michalak, Zuzanna
    Dwyer, Michael
    Benedict, Ralph
    Weinstock-Guttman, Bianca
    Kuhle, Jens
    Zivadinov, Robert
    NEUROLOGY, 2019, 92 (15)
  • [30] Serum Neurofilament Light Chain as Biomarker for Cladribine-Treated Multiple Sclerosis Patients in a Real-World Setting
    Seiberl, Michael
    Feige, Julia
    Hilpold, Patrick
    Hitzl, Wolfgang
    Machegger, Lukas
    Buchmann, Arabella
    Khalil, Michael
    Trinka, Eugen
    Harrer, Andrea
    Wipfler, Peter
    Moser, Tobias
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (04)
12345